Skip to content

Contango Silver & Gold CTGO Proceeds From Issuance Of Common Stock And Warrant Net

Proceeds From Issuance Of Common Stock And Warrant Net at other companies

Esperion Therapeutics logo
Esperion TherapeuticsESPR
$18.15M-19.9%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$81.01M-28.0%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$0
Arvinas logo
ArvinasARVN
$0
Vaxcyte, Inc. logo
Vaxcyte, Inc.PCVX
$0-100%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$5.86M

Other financials

Income statement

See full
Operating income$4.8M-75.0%
Net income-$14.3M+36.6%
EPS (diluted)-$0.83+55.9%

Balance sheet

See full
Cash & equivalents$97.5M+179%
Total debt$33.0M-41.2%
Total equity$321.5M+1,668%
Total assets$496.2M+237%

Cash flow

See full
Operating cash flow-$49.6M-274%
CapEx$150.5K
Free cash flow$23.3M+33.2%

Valuation

See full
Market cap$459.11M+81.8%
Enterprise value$394.63M+44.2%

Returns & leverage

See full
Return on equity-273.7%
Debt / equity0.1×
Current ratio1.3×+0.9×

Where this comes from

Reported directly by Contango Silver & Gold in its filing.

Tagged under the XBRL concept ctgo:ProceedsFromIssuanceOfCommonStockAndWarrantNet.

The official record: Contango Silver & Gold ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Contango Silver & Gold 's proceeds from issuance of common stock and warrant net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Contango Silver & Gold 's proceeds from issuance of common stock and warrant net?
Contango Silver & Gold (CTGO) reported proceeds from issuance of common stock and warrant net of $52.44M in Q1 2026.
How has Contango Silver & Gold 's proceeds from issuance of common stock and warrant net changed year-over-year?
Contango Silver & Gold 's proceeds from issuance of common stock and warrant net increased by 6463.4% year-over-year, from $798.92K to $52.44M.
What is the long-term trend for Contango Silver & Gold 's proceeds from issuance of common stock and warrant net?
Over 2 years (2023 to 2025), Contango Silver & Gold 's proceeds from issuance of common stock and warrant net has grown at a 121.2% compound annual growth rate (CAGR), from $11.56M to $56.59M.
What does proceeds from issuance of common stock and warrant net mean?
This represents the net cash inflow resulting from the sale of common equity and associated warrants to investors. It reflects the company's ability to raise external capital to fund operations or exploration activities. Analysts monitor this to assess potential shareholder dilution and the company's reliance on equity markets.